Clinical Trials Directory

Trials / Sponsors / Furiex Pharmaceuticals, Inc

Furiex Pharmaceuticals, Inc

Industry · 6 registered clinical trials.

StatusTrialPhaseStarted
CompletedEfficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant I
Irritable Bowel Syndrome
Phase 32012-05-29
CompletedEfficacy, Safety, and Tolerability of Eluxadoline in the Treatment of Participants With Diarrhea-Predominant I
Irritable Bowel Syndrome
Phase 32012-05-29
CompletedStudy of the Safety and Tolerability Associated With PPD10558 Versus Atorvastatin in Patients Previously Intol
Myalgia, Hypercholesterolemia, Hyperlipidemia
Phase 22011-03-01
TerminatedEfficacy and Safety Study of JNJ-32729463 Compared With Moxifloxacin for the Treatment of Subjects Requiring H
Community-Acquired Bacterial Pneumonia (CABP)
Phase 22010-10-01
CompletedEfficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared
Complicated Skin and Skin Structure Infections
Phase 22010-06-01
CompletedEfficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome
Irritable Bowel Syndrome
Phase 22010-04-28